THE EARLY INFLIXIMAB LEVELS MONITORING CAN PREDICT THE DEVELOPEMENT OF ANTI-DRUG ANTIBODIES IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB

被引：1
|
作者：
Chamaida, P. -R. [1 ]
Pascual-Salcedo, D. [1 ]
Bonilla, M. [1 ]
Villalba, A. [1 ]
Lopez-Casla, M. [2 ]
Peiteado, D. [1 ]
Garcia-Carazo, S. [1 ]
Ramiro, S. [2 ]
Franco, K. [1 ]
Cajigas, D. [1 ]
Martin-Mola, E. [1 ]
Balsa, A. [1 ]
机构：
[1] La Paz Univ Hosp, Rheumatol, Madrid, Spain
[2] La Paz Univ Hosp, Immunol, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.3237
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0253
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [1] The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
    Plasencia-Rodriguez, Chamaida
    Pascual-Salcedo, Dora
    Gema Bonilla, Maria
    Villalba, Alejandro
    Peiteado, Diana
    Nuno, Laura
    Aguado, Pilar
    Jurado, Teresa
    Martin-Mola, Emilio
    Balsa, Alejandro
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1098 - S1098
  • [2] Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis
    Siljehult, F.
    Arlestig, L.
    Eriksson, C.
    Rantapaa-Dahlqvist, S.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (05) : 345 - 350
  • [3] Incidence of Anti-Drug Antibodies in Rheumatoid Arthritis Patients Treated with Adalimumab, Etanercept, or Infliximab in a Real-World Setting
    Moots, R. J.
    Xavier, Ricardo
    Mok, Chi Chiu
    Rahman, Mahboob U.
    Tsai, Wen-Chan
    Al Maini, Mustafa
    Pavelka, Karel
    Mahgoub, Ehab
    Kotak, Sameer
    Korth-Bradley, Joan
    Pedersen, Ronald
    Mele, Linda
    Shen, Qi
    Vlahos, Bonnie
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] The temporal evolution of anti-drug antibodies in IBD patients treated with infliximab
    Ben-Horin, Shomron
    Ungar, Bella
    Chowers, Yehuda
    Yavzori, Miri
    Picard, Orit
    Fudim, Ella
    Eliakim, Rami
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 145 - 145
  • [5] INCIDENCE AND CLINICAL OUTCOME OF ANTI-DRUG ANTIBODIES IN INFLIXIMAB-TREATED PATIENTS
    Bartoli, F.
    Fiori, G.
    Galluccio, F.
    Petroni, G.
    Pratesi, S.
    Matucci, A.
    Vultaggio, A.
    Nacci, F.
    Nencini, F.
    Maggi, E.
    Matucci-Cerinic, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 514 - 514
  • [6] Anti-Drug Antibodies in Patients with Inflammatory Bowel Diseases Treated with Biosimilar Infliximab: A Prospective Cohort Study
    Pekala, Anna
    Filip, Rafal
    Aebisher, David
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [7] Detection of anti-infliximab antibodies is of limited value to predict acquired drug resistance to infliximab in rheumatoid arthritis
    Finckh, Axel
    Dudler, Jean
    Wennelinger, Felix
    Ciurca, Adrian
    Gabay, Cem
    Bas, Sylvette
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S777 - S777
  • [8] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    Aatke van der Maas
    Bart JF van den Bemt
    Gertjan Wolbink
    Frank HJ van den Hoogen
    Piet LCM van Riel
    Alfons A den Broeder
    [J]. BMC Musculoskeletal Disorders, 13
  • [9] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    van der Maas, Aatke
    van den Bemt, Bart J. F.
    Wolbink, Gertjan
    van den Hoogen, Frank H. J.
    van Riel, Piet L. C. M.
    den Broeder, Alfons A.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [10] FEMALE GENDER AND POSITIVE RHEUMATOID FACTOR PREDICT LOW SERUM INFLIXIMAB LEVELS AND POSITIVE ANTI-DRUG ANTIBODIES, WHICH ASSOCIATE WITH TREATMENT FAILURE ON INFLIXIMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS. REPORT FROM THE SWEFOT TRIAL POPULATION
    Hambardzumyan, K.
    Hermanrud, C.
    Marits, P.
    Vivar, N.
    Ernestam, S.
    Wallman, J. K.
    van Vollenhoven, R. F.
    Fogdell-Hahn, A.
    Saevarsdottir, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 165 - 165
12345